Hyperbilirubinemia: Current guidelines and emerging therapies

Pediatric Emergency Care

Volumn 27, Issue 9, 2011, Pages 884-889

  Schwartz, Hamilton P ^a,b   Haberman, Beth E ^a,b,c   Ruddy, Richard M ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Regional Center for Newborn Intensive Care   (United States)

Author keywords

Hyperbilirubinemia; kernicterus; pathologic jaundice; phototherapy; physiologic jaundice; transcutaneous bilirubin measurement

Indexed keywords

IMMUNOGLOBULIN; MESOPORPHYRIN; PHENOBARBITAL; URSODEOXYCHOLIC ACID;

BILIRUBIN BLOOD LEVEL; BREAST FEEDING; CLINICAL FEATURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; EMERGENCY MEDICINE; EXCHANGE BLOOD TRANSFUSION; HUMAN; HYPERBILIRUBINEMIA; IMMUNIZATION; INFECTION; JAUNDICE; KERNICTERUS; PHOTOTHERAPY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

BILIRUBIN; BLOOD GROUP INCOMPATIBILITY; BREAST FEEDING; DIAGNOSIS, DIFFERENTIAL; EMERGENCIES; ERYTHROBLASTOSIS, FETAL; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HEMOGLOBINOPATHIES; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; MALE; METABOLISM, INBORN ERRORS; METALLOPORPHYRINS; PHOTOTHERAPY; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; RH ISOIMMUNIZATION; SEPSIS;

EID: 80052997692     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31822c9b4c     Document Type: Review

References (39)

1. Maisels MJ. Jaundice. In: Avery GB, MacDonald MG, SeshiaMMK, eds, Avery's neonatology: Pathophysiology & Management of the Newborn. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
2. Sacchetti AD, Gerardi M, Sawchuk P, et al. Boomerang babies: Emergency department utilization by early discharge neonates. Pediatr Emerg Care. 1997;13:365-368. (Pubitemid 28008839)
3. US Department of Health and Human Services. 2006 National statistics. All ED visits for hemolytic jaundice and perinatal jaundice (those that resulted in admission to the hospital and those that did not). Healthcare Cost and Utilization Project Web site, HCUPnet. Available at http://hcupnet.ahrq.gov/. Accessed February 1, 2010.
4. Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003;29:410-421. (Pubitemid 37543676)
5. Maisels MJ. Neonatal jaundice. Pediatr Rev. 2006;27:443-454. (Pubitemid 46495865)
6. Colletti JE, Kothari S, Jackson DM, et al. An emergency medicine approach to neonatal hyperbilirubinemia. Emerg Med Clin North Am. 2007;25:1117-1135. (Pubitemid 47562657)
7. Schroter W, Kahsnitz E. Diagnosis of hereditary spherocytosis in newborn infants. J Pediatr. 1983;103:460-463. (Pubitemid 13000469)
8. Iranpour R, Akbar MR, Haghshenas I. Glucose-6-phosphate dehydrogenase deficiency in neonates. Indian J Pediatr. 2003;70:855-857. (Pubitemid 38017019)
9. Strauss KA, Robinson DL, Vreman HJ, et al. Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr. 2006;165:306-319.
10. AAP Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297-316.
11. Bertini G, Dani C, Tronchin M, et al. Is breastfeeding really favoring early neonatal jaundice? Pediatrics. 2001;107:E41.
12. Maisels MJ, Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast-feeding. Pediatrics. 1986;78:837-843. (Pubitemid 17170692)
13. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995;96:730-733.
14. Schneider AP 2nd. Breast milk jaundice in the newborn. A real entity. JAMA. 1986;255:3270-3274. (Pubitemid 16122589)
15. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396-403. (Pubitemid 34494310)
16. Volpe JJ. Bilirubin and brain injury. In: Volpe JJ, ed. Neurology of the Newborn. 5th ed. Philadelphia, PA: WB Saunders; 2008.
17. Maisels MJ, Kring E. Risk of sepsis in newborns with severe hyperbilirubinemia. Pediatrics. 1992;90:741-743. (Pubitemid 23008193)
18. Seidman DS, Stevenson DK, Ergaz Z, et al. Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics. 1995;96:727-729.
19. Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med. 2000;154:391-394. (Pubitemid 30198489)
20. Fetus and Newborn Committee, Canadian Paediatric Society. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation)Vsummary. Paediatr Child Health. 2007;12:401-418.
21. Joint Commission on Accrediation of Healthcare Organizations. Kernicterus threatens healthy newborns. Sentinel Event Alert. 2001:1-4.
22. Bhutani VK, Maisels MJ, Stark AR, et al. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants 9 or = 35 weeks gestation. Neonatology. 2008;94:63-67. (Pubitemid 351896597)
23. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358:920-928. (Pubitemid 351397091)
24. Diamond LK, Allen FH Jr, Thomas WO Jr. Erythroblastosis fetalis. VII. Treatment with exchange transfusion. N Engl J Med. 1951;244:39-49.
25. Steiner LA, Bizzarro MJ, Ehrenkranz RA, et al. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics. 2007;120:27-32. (Pubitemid 47036237)
26. Hsia DY, Allen FH Jr, Gellis SS, et al. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus. Engl J Med. 1952;247:668-671.
27. Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of healthy full-term infants? Clin Perinatol. 1990;17:331-358.
28. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: A kinder, gentler approach. Pediatrics. 1992;89:809-818.
29. Bhutani VK, Gourley GR, Adler S, et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106:e17.
30. Maisels MJ, Bhutani VK, Bogen D, et al. Hyperbilirubinemia in the newborn infant 9 or =35 weeks' gestation: An update with clarifications. Pediatrics. 2009;124:1193-1198.
31. Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of 9 or = 35 weeks' gestation. Pediatrics. 2006;117:1169-1173. (Pubitemid 46071509)
32. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6-14. (Pubitemid 29281921)
33. Fouzas S, Mantagou L, Skylogianni E, et al. Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. Pediatrics. 2010;125:e52-e57; originally published online December 14, 2009.
34. Engle WD, Lai S, Ahmad N, et al. An hour-specific nomogram for transcutaneous bilirubin values in term and late preterm Hispanic neonates. Am J Perinatol. 2009;26:425-430.
35. Lam TS, Tsui KL, Kam CW. Evaluation of a point-of-care transcutaneous bilirubinometer in Chinese neonates at an accident and emergency department. Hong Kong Med J. 2008;14:356-360.
36. Yaffe SJ, Levy G, Matsuzawa T, et al. Enhancement of glucuronide- conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. N Engl J Med. 1966;275:1461-1466.
37. Dennery PA. Metalloporphyrins for the treatment of neonatal jaundice. Curr Opin Pediatr. 2005;17:167-169. (Pubitemid 40516093)
38. Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev. 2002:CD003313.
39. Monpoux F, Dageville C, Maillotte AM, et al. High-dose intravenous immunoglobulin therapy and neonatal jaundice due to red blood cell alloimmunization. Arch Pediatr. 2009;16:1289-1294.